We are live on ! Find out more
LSC

Lyon Street Capital Portfolio holdings

AUM $67M
This Fund
S&P 500
This Quarter Est. Return
+21.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$300M
AUM Growth
+$40.5M
Cap. Flow
+$2.32M
Cap. Flow %
0.77%
Top 10 Hldgs %
46.35%
Holding
64
New
9
Increased
20
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
+$11.5M
2
BEAT
BioTelemetry, Inc.
BEAT
+$10.5M
3
SBBP
Strongbridge Biopharma plc.
SBBP
+$6.19M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$5.52M
5
NEOS
Neos Therapeutics, Inc
NEOS
+$5.36M

Top Sells

Rank Stock Value
1
STMP
Stamps.com, Inc.
STMP
+$5.42M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$5.21M
3
HLF icon
Herbalife
HLF
+$5.05M
4
EHTH icon
eHealth
EHTH
+$4.59M
5
AXGN icon
Axogen
AXGN
+$4.14M

Sector Composition

Rank Sector Weight
1 Healthcare 33.34%
2 Technology 18.99%
3 Financials 14.84%
4 Communication Services 9.98%
5 Industrials 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSEM icon
26
Tower Semiconductor
TSEM
$26.5B
$4.59M 1.53%
134,682
– –
IVTY
27
DELISTED
Invuity, Inc
IVTY
$4.51M 1.5%
727,510
-155,845
-18% -$1.27M
RSPP
28
DELISTED
RSP Permian, Inc.
RSPP
$4.42M 1.47%
108,693
– –
HLF icon
29
Herbalife
HLF
$1.32B
$4.23M 1.41%
125,000
-144,064
-54% -$5.05M
PDFS icon
30
PDF Solutions
PDFS
$2.01B
$4.01M 1.34%
255,398
-116,185
-31% -$1.87M
QUOT
31
DELISTED
Quotient Technology Inc
QUOT
$3.82M 1.27%
324,918
-173,608
-35% -$2.41M
IRIX icon
32
IRIDEX
IRIX
$14.4M
$3.69M 1.23%
483,760
+41,113
+9% +$352K
GDOT icon
33
Green Dot
GDOT
$754M
$3.42M 1.14%
56,699
-62,012
-52% -$3.64M
BLDR icon
34
Builders FirstSource
BLDR
$7.8B
$3.41M 1.14%
156,289
-196,806
-56% -$3.73M
SCTL
35
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3.36M 1.12%
+405,297
New +$3.32M
FANG icon
36
Diamondback Energy
FANG
$55.9B
$3.26M 1.09%
25,800
– –
BOX icon
37
Box
BOX
$4.39B
$3.17M 1.06%
150,000
+25,000
+20% +$527K
SUP
38
DELISTED
Superior Industries International
SUP
$2.85M 0.95%
192,180
-898
-0.5% -$14.3K
BFH icon
39
Bread Financial
BFH
$4.48B
$2.54M 0.85%
+12,530
New +$2.32M
MRVL icon
40
Marvell Technology
MRVL
$174B
$2.51M 0.84%
117,053
– –
MCHB
41
Mechanics Bancorp
MCHB
$3.77B
$2.28M 0.76%
78,799
+20,599
+35% +$598K
CIVI
42
DELISTED
Civitas Resources
CIVI
$2.19M 0.73%
79,278
– –
URGN icon
43
UroGen Pharma
URGN
$1.88B
$2.11M 0.7%
56,617
+14,876
+36% +$530K
LSAK icon
44
Lesaka Technologies
LSAK
$401M
$2.04M 0.68%
+171,868
New +$1.74M
AXAS
45
DELISTED
Abraxas Petroleum Corp
AXAS
$1.67M 0.56%
34,030
– –
SREV
46
DELISTED
ServiceSource International, Inc.
SREV
$1.45M 0.48%
469,622
– –
ELDN icon
47
Eledon Pharmaceuticals
ELDN
$265M
$1.38M 0.46%
18,829
+9,519
+102% +$719K
EXPR
48
DELISTED
Express, Inc.
EXPR
$928K 0.31%
+4,572
New +$750K
MCRI icon
49
Monarch Casino & Resort
MCRI
$2.24B
$803K 0.27%
+17,909
New +$794K
IMMR icon
50
Immersion
IMMR
$248M
$773K 0.26%
+109,468
New +$792K
1
2
3

Similar funds

DCM
Dockyard Capital Management Boston, Massachusetts $70.6M AUM
SCMU
Steadfast Capital Management (UK) London, United Kingdom $71.5M AUM
TLCM
Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return
EA
Elm Advisors Burlingame, California $74.1M AUM 7.85% 1-Year Est. Return
A
Astrantus Limassol, Cyprus $59.4M AUM
AAI
Accomplice Associates II Boston, Massachusetts $57.8M AUM
EM
Endicott Management New York $81.7M AUM 36.01% 1-Year Est. Return
ALFA
Accel Leaders Fund Associates Palo Alto, California $51.5M AUM

Lyon Street Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Lyon Street Capital held 64 positions worth $300M, up 16% from $259M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lyon Street Capital's Q4 2017 filing shows 9 new, 20 increased, 13 reduced and 11 closed positions. Its largest new stake was Ligand Pharmaceuticals: 63,729 shares worth $5.44M. The largest sale was Stamps.com, Inc., an estimated $5.42M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Lyon Street Capital's largest Q4 2017 buy was Ligand Pharmaceuticals: 63,729 shares worth $5.44M.
  • Lyon Street Capital added most to Benefytt Technologies, Inc. Class A Common Stock in Q4 2017, an estimated $11.5M increase.
  • Lyon Street Capital's biggest Q4 2017 reduction was Concert Pharmaceuticals, Inc., cutting an estimated $5.21M.
  • Lyon Street Capital fully exited Stamps.com, Inc. in Q4 2017, selling an estimated $5.42M.
  • Lyon Street Capital's ten largest holdings make up 46% of its $300M portfolio in Q4 2017.
  • Lyon Street Capital opened 9 new positions and closed 11 in Q4 2017.
  • Lyon Street Capital's portfolio value rose 16% quarter-over-quarter to $300M.

Based on Lyon Street Capital's 13F filing for Q4 2017, filed 14 Feb 2018.